EUVIMEDEUVIMED entdecken
Crossref

Antidiabetic effect of Saurauia bracteosa through GSK-3β inhibition: Insights from phytochemical analysis, molecular docking, and glucose uptake in L6 cells

Marianne Marianne, Poppy Anjelisa Zaitun Hasibuan, Yuandani Yuandani, Kamal Rullah, Md. Nazim Uddin, Yoon A Jeon, Young Jae Lee

Journal of Herbmed Pharmacology · 01.01.2026 · 15 (1) · 95-108

DOI: 10.34172/jhp.2026.53352 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Herbmed Pharmacology, online erschienen am 01.01.2026. Verfasst von Marianne Marianne und 6 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Saurauia bracteosa is a medicinal plant traditionally used by the Batak Toba and Karo ethnic groups of North Sumatra, Indonesia, to manage type 2 diabetes mellitus (T2DM). However, the precise molecular mechanisms responsible for its antidiabetic effect remain unclear. Thus, the purpose of this study was to investigate the mechanisms of action of S. bracteosa leaf extract and assess its potential in treating type 2 diabetes.

Methods

Phytochemical profiling was conducted using LC-MS/MS and GC-MS. Key active compounds, including ursolic acid and quercetin, were quantified by UPLC, and their effects on glucose uptake in L6 skeletal muscle cells were evaluated. To learn more about possible molecular pathways, network pharmacology and molecular docking were used.

Results

The extract was found to contain triterpenoids and flavonoids such as ursolic acid and quercetin, which significantly enhanced glucose uptake in L6 cells with effects comparable to insulin (P>0.05). Network pharmacology identified multiple gene targets, with pathway enrichment analysis highlighting glycogen synthase kinase-3 beta (GSK3β) as a central protein. Molecular docking confirmed the strong binding affinity of quercetin to GSK3β, supporting its potential role in modulating insulin signaling.

Conclusion

These results suggest that GSK3β regulation and enhanced glucose absorption in skeletal muscle cells may be involved in the antidiabetic action of S. bracteosa. This provides a scientific basis for its traditional use and highlights its potential for further development as a natural therapeutic option for diabetes.

Zitieren

APA

Marianne, M., Hasibuan, P. A. Z., Yuandani, Y., Rullah, K., Uddin, M. N., Jeon, Y. A., & Lee, Y. J. (2026). Antidiabetic effect of Saurauia bracteosa through GSK-3β inhibition: Insights from phytochemical analysis, molecular docking, and glucose uptake in L6 cells. Journal of Herbmed Pharmacology, 15(1), 95-108. https://doi.org/10.34172/jhp.2026.53352

Vancouver

Marianne M, Hasibuan PAZ, Yuandani Y, Rullah K, Uddin MN, Jeon YA, et al. Antidiabetic effect of Saurauia bracteosa through GSK-3β inhibition: Insights from phytochemical analysis, molecular docking, and glucose uptake in L6 cells. Journal of Herbmed Pharmacology. 2026;15(1):95-108. doi:10.34172/jhp.2026.53352

BibTeX
@article{Marianne2026,
  author = {Marianne, Marianne and Hasibuan, Poppy Anjelisa Zaitun and Yuandani, Yuandani and Rullah, Kamal and Uddin, Md. Nazim and Jeon, Yoon A and Lee, Young Jae},
  title = {Antidiabetic effect of Saurauia bracteosa through GSK-3β inhibition: Insights from phytochemical analysis, molecular docking, and glucose uptake in L6 cells},
  journal = {Journal of Herbmed Pharmacology},
  year = {2026},
  volume = {15},
  number = {1},
  pages = {95--108},
  doi = {10.34172/jhp.2026.53352}
}
Kostenlos starten →